BlackRock Health Sciences Trust (BME) To Go Ex-Dividend on September 15th

BlackRock Health Sciences Trust (NYSE:BME) announced a monthly dividend on Friday, June 5th. Stockholders of record on Tuesday, September 15th will be paid a dividend of 0.2621 per share on Wednesday, September 30th. This represents a c) dividend on an annualized basis and a dividend yield of 7.1%. The ex-dividend date of this dividend is Tuesday, September 15th.

BlackRock Health Sciences Trust Stock Performance

Shares of NYSE BME opened at $44.26 on Friday. The company has a 50 day simple moving average of $44.20 and a 200-day simple moving average of $41.51. BlackRock Health Sciences Trust has a 1 year low of $35.95 and a 1 year high of $46.42.

Institutional Investors Weigh In On BlackRock Health Sciences Trust

Several hedge funds and other institutional investors have recently added to or reduced their stakes in the business. Northwestern Mutual Wealth Management Co. lifted its stake in shares of BlackRock Health Sciences Trust by 285,436.7% in the 4th quarter. Northwestern Mutual Wealth Management Co. now owns 4,046,055 shares of the company’s stock valued at $166,414,000 after purchasing an additional 4,044,638 shares during the last quarter. Bank of America Corp DE purchased a new stake in BlackRock Health Sciences Trust in the 2nd quarter valued at about $11,827,000. 1607 Capital Partners LLC lifted its position in BlackRock Health Sciences Trust by 49.5% in the fourth quarter. 1607 Capital Partners LLC now owns 229,260 shares of the company’s stock valued at $9,429,000 after buying an additional 75,958 shares during the last quarter. Invesco Ltd. boosted its stake in BlackRock Health Sciences Trust by 7.6% during the third quarter. Invesco Ltd. now owns 217,169 shares of the company’s stock worth $8,085,000 after buying an additional 15,381 shares during the period. Finally, Royal Bank of Canada increased its position in shares of BlackRock Health Sciences Trust by 13.0% during the fourth quarter. Royal Bank of Canada now owns 160,464 shares of the company’s stock valued at $6,600,000 after acquiring an additional 18,442 shares during the last quarter.

About BlackRock Health Sciences Trust

BlackRock Health Sciences Trust (NYSE: BME) is a closed-end management investment company that seeks long-term total return through a combination of dividend income and capital appreciation. Managed by BlackRock Fund Advisors, the trust invests primarily in the equity securities of domestic and international issuers engaged in the health sciences sector. The portfolio typically includes common stocks, corporate bonds and convertible securities of companies involved in biotechnology, pharmaceuticals, medical devices and healthcare services.